BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36041714)

  • 1. Klotho restoration via ACE2 activation: A potential therapeutic strategy against acute kidney injury-diabetes comorbidity.
    Kale A; Shelke V; Sankrityayan H; Dagar N; Gaikwad AB
    Biochim Biophys Acta Mol Basis Dis; 2022 Dec; 1868(12):166532. PubMed ID: 36041714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic restoration of endogenous Klotho expression alleviates acute kidney injury-diabetes comorbidity.
    Kale A; Sankrityayan H; Gaikwad AB
    Life Sci; 2022 Jan; 288():120194. PubMed ID: 34864061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACE2 activator diminazene aceturate exerts renoprotective effects in gentamicin-induced acute renal injury in rats.
    Silva de Almeida TC; Lanza K; da Silva Filha R; C Campos LMC; Fonseca EG; Chagas MW; Rocha NP; de Sá MA; Vieira MAR; Caliari MV; Kangussu LM; Ferreira AJ; Simões E Silva AC
    Clin Sci (Lond); 2020 Dec; 134(23):3093-3106. PubMed ID: 33206153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ER stress modulated Klotho restoration: A prophylactic therapeutic strategy against acute kidney injury-diabetes comorbidity.
    Kale A; Shelke V; Habshi T; Dagar N; Gaikwad AB
    Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166905. PubMed ID: 37793463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II type 2 receptor and angiotensin-converting enzyme 2 mediate ischemic renal injury in diabetic and non-diabetic rats.
    Sharma N; Malek V; Mulay SR; Gaikwad AB
    Life Sci; 2019 Oct; 235():116796. PubMed ID: 31470003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of renal ischemia injury on brain in diabetic and non-diabetic rats: Role of angiotensin II type 2 receptor and angiotensin-converting enzyme 2.
    Sharma N; Gaikwad AB
    Eur J Pharmacol; 2020 Sep; 882():173241. PubMed ID: 32565336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of ACE2 exacerbates murine renal ischemia-reperfusion injury.
    Fang F; Liu GC; Zhou X; Yang S; Reich HN; Williams V; Hu A; Pan J; Konvalinka A; Oudit GY; Scholey JW; John R
    PLoS One; 2013; 8(8):e71433. PubMed ID: 23951161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ameliorative effect of AT2R and ACE2 activation on ischemic renal injury associated cardiac and hepatic dysfunction.
    Sharma N; Gaikwad AB
    Environ Toxicol Pharmacol; 2020 Nov; 80():103501. PubMed ID: 32979558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective.
    Hu MC; Shi M; Zhang J; Quiñones H; Kuro-o M; Moe OW
    Kidney Int; 2010 Dec; 78(12):1240-51. PubMed ID: 20861825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme 2 (ACE2) activator diminazene aceturate ameliorates endotoxin-induced uveitis in mice.
    Qiu Y; Shil PK; Zhu P; Yang H; Verma A; Lei B; Li Q
    Invest Ophthalmol Vis Sci; 2014 May; 55(6):3809-18. PubMed ID: 24854854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renoprotective effect of esculetin against ischemic acute kidney injury-diabetic comorbidity.
    Dagar N; Habshi T; Shelke V; Jadhav HR; Gaikwad AB
    Free Radic Res; 2024 Feb; 58(2):69-87. PubMed ID: 38323807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. View of the Renin-Angiotensin System in Acute Kidney Injury Induced by Renal Ischemia-Reperfusion Injury.
    Karimi F; Maleki M; Nematbakhsh M
    J Renin Angiotensin Aldosterone Syst; 2022; 2022():9800838. PubMed ID: 36320442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent neprilysin inhibition and renin-angiotensin system modulations prevented diabetic nephropathy.
    Malek V; Sharma N; Sankrityayan H; Gaikwad AB
    Life Sci; 2019 Mar; 221():159-167. PubMed ID: 30769114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of captopril treatment on recuperation from ischemia/reperfusion-induced acute renal injury.
    Efrati S; Berman S; Hamad RA; Siman-Tov Y; Ilgiyaev E; Maslyakov I; Weissgarten J
    Nephrol Dial Transplant; 2012 Jan; 27(1):136-45. PubMed ID: 21680852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of angiotensin-converting enzyme (ACE and ACE2) imbalance on tourniquet-induced remote kidney injury in a mouse hindlimb ischemia-reperfusion model.
    Yang XH; Wang YH; Wang JJ; Liu YC; Deng W; Qin C; Gao JL; Zhang LY
    Peptides; 2012 Jul; 36(1):60-70. PubMed ID: 22580272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diminazene aceturate prevents nephropathy by increasing glomerular ACE2 and AT
    Goru SK; Kadakol A; Malek V; Pandey A; Sharma N; Gaikwad AB
    Br J Pharmacol; 2017 Sep; 174(18):3118-3130. PubMed ID: 28688122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diminazene Aceturate, an angiotensin converting enzyme 2 (ACE2) activator, promotes cardioprotection in ischemia/reperfusion-induced cardiac injury.
    Coutinho DCO; Santos-Miranda A; Joviano-Santos JV; Foureaux G; Santos A; Rodrigues-Ferreira C; Martins-Júnior PA; Resende RR; Medei E; Vieyra A; Santos RAS; Cruz JS; Ferreira AJ
    Peptides; 2022 May; 151():170746. PubMed ID: 35033621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme 2 activator diminazene aceturate prevents lipopolysaccharide-induced inflammation by inhibiting MAPK and NF-κB pathways in human retinal pigment epithelium.
    Tao L; Qiu Y; Fu X; Lin R; Lei C; Wang J; Lei B
    J Neuroinflammation; 2016 Feb; 13():35. PubMed ID: 26862037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calpain Inhibitor Calpeptin Alleviates Ischemia/Reperfusion-Induced Acute Kidney Injury
    Wu Y; Yang H; Cheng M; Shi J; Zhang W; Liu S; Zhang M
    Front Med (Lausanne); 2022; 9():811980. PubMed ID: 35155498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE2 Attenuates Epithelial-Mesenchymal Transition in MLE-12 Cells Induced by Silica.
    Li S; Li Y; Xu H; Wei Z; Yang Y; Jin F; Zhang M; Wang C; Song W; Huo J; Zhao J; Yang X; Yang F
    Drug Des Devel Ther; 2020; 14():1547-1559. PubMed ID: 32368013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.